Author Archives: Lee Jackson

analysis

Jefferies Top Stocks to Buy May Have Market-Moving Catalysts

One of the things that stock investors love is when a company has a catalyst coming that can boost share price. That can range from a stock buyback program to ...
Read Full Story »
KMI Tanker

China’s Oil Demand Is Huge and Growing: 4 Dividend-Paying Oil Stocks to Buy Now

Supply glut, the two words that seem to haunt the energy sector constantly. While that may remain a near-term issue, the longer term issue is demand, as well as the lack ...
Read Full Story »
automatic inspection machine

Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy This Week

With one presidential debate out of the way, and more right around the corner, one thing is for sure: at one point pharmaceutical costs and pricing may come up, and ...
Read Full Story »
Light Switch

Merrill Lynch Makes a Huge Change to Prestigious US 1 Portfolio

With earnings for the third quarter on deck, and the fourth quarter of 2016 almost underway, many of the top companies we follow on Wall Street are making some changes ...
Read Full Story »
Facebook corporate

JPMorgan Raises Price Targets on FANG Stocks in a Big Way

What was super-big in 2015, the so-called FANG stocks, took a dive to start this year, and as is inevitable, the perma-bears on Wall Street took to the airwaves and ...
Read Full Story »
oil tanks

4 MLPs to Buy That Should Do Fine When Rates Inevitably Go Higher

While the Federal Reserve declined to raise rates last week, the writing is starting to be on the proverbial wall. The fact that three Fed governors dissented, and the employment ...
Read Full Story »
crash

4 Dividend Stocks That Likely Could Survive a Market Crash

September will be over this week, but the other month that can sometimes prove dangerous is on deck. October has been notorious when it comes to big sell-offs, and while ...
Read Full Story »
Intel processor

Merrill Lynch Has 4 Top Tech Dividend Stocks to Buy for Q4

With less than a week left in the third quarter, earnings reports soon will be flying fast and furious, and many investors are trying to get their portfolios set for ...
Read Full Story »
Pump Jacks Against at Dusk

Deutsche Bank Says Permian Basin Oil Stocks Still Best Buys

Analysts across Wall Street remain very positive on exploration and production companies that are doing the lion's share of their drilling in the Permian basin in West Texas. While many ...
Read Full Story »
investing

Jefferies Makes Huge New Stock Addition to Franchise Picks List

With earnings for the third quarter on deck, and the fourth quarter of 2016 almost underway, many of the top companies we follow on Wall Street are making some changes ...
Read Full Story »
roller-coaster

Giant Biotech and Energy Insider Buys Highlight Wild Market Week: Chesapeake Energy, Cheniere Energy, Phillips 66 and More

Once again, the roller-coaster that is the stock market took investors on a wild ride, and this time is was mostly higher. A massive rally shot all the indexes higher ...
Read Full Story »
hospital

Massive Health Care Trade Highlights Insider Selling: Acadia Healthcare, MSCI, NVIDIA, Activision Blizzard and More

In a week that saw more swings than we have seen in some time, once again insiders were making transactions that may be getting done now in an effort to ...
Read Full Story »
Red Stapler

3 Dividend Stocks Trading at 5-Year Lows Could Have Big Upside Potential

The often asked question when the markets continue to hit or trade at all-time highs is what and where to look for ideas, especially if dividends are important? Chasing the bond ...
Read Full Story »
whisky

These 5 Sin Stocks Have Solid Upside Potential and Pay Big Dividends

One of the categories on Wall Street that some portfolio managers really don’t want to discuss in their portfolios is the so-called sin stocks. These are companies that sell tobacco and ...
Read Full Story »
graph

Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential

Needless to say, the biotech world has had a very difficult year. Even the biggest and the best companies, many of which trade cheaper than big pharmaceutical companies, have suffered ...
Read Full Story »